Sinovac reports positive data from Phase I/II trials of CoronaVac
CoronaVac is an inactivated vaccine candidate intended to protect against Covid-19. Credit: Sinovac Biotech Ltd.
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.ContinueLearn more